Junko Tanaka

12.8k total citations
317 papers, 4.7k citations indexed

About

Junko Tanaka is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Junko Tanaka has authored 317 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 163 papers in Epidemiology, 151 papers in Hepatology and 29 papers in Infectious Diseases. Recurrent topics in Junko Tanaka's work include Liver Disease Diagnosis and Treatment (121 papers), Hepatitis C virus research (114 papers) and Hepatitis B Virus Studies (97 papers). Junko Tanaka is often cited by papers focused on Liver Disease Diagnosis and Treatment (121 papers), Hepatitis C virus research (114 papers) and Hepatitis B Virus Studies (97 papers). Junko Tanaka collaborates with scholars based in Japan, Cambodia and Burkina Faso. Junko Tanaka's co-authors include Tomoyuki Akita, Takashi Kumada, Hidenori Toyoda, Hiroshi Yoshizawa, Toshifumi Tada, Keiko Katayama, Yuzo Miyakawa, Masaaki Mizui, Aya Sugiyama and Masayuki Ohisa and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

Junko Tanaka

286 papers receiving 4.6k citations

Peers

Countries citing papers authored by Junko Tanaka

Since Specialization

Citations

This map shows the geographic impact of Junko Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junko Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junko Tanaka more than expected).

Fields of papers citing papers by Junko Tanaka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junko Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junko Tanaka. The network helps show where Junko Tanaka may publish in the future.

Co-authorship network of co-authors of Junko Tanaka

This figure shows the co-authorship network connecting the top 25 collaborators of Junko Tanaka. A scholar is included among the top collaborators of Junko Tanaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junko Tanaka. Junko Tanaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Suppressive effect of vitamin K2 (menatetrenone) against bone mineral density loss after radiotherapy in uterine cancer patients 2025 ·Japanese Journal of Radiology ·Yuko Kaneyasu, Hisaya Fujiwara, Tomoyuki Akita, Junko Tanaka, (unknown), (unknown), (unknown), Eiji Hirata, (unknown), Tadashi Miyamoto, Yuji Murakami, Ikuno Nishibuchi, Nobuki Imano, Yasushi Nagata, Yoshiki Kudo	0
2	Advanced fibrosis leads to overestimation of steatosis with quantitative ultrasound in individuals without hepatic steatosis 2024 ·ULTRASONOGRAPHY ·Takashi Kumada, Hidenori Toyoda, Sadanobu Ogawa, (unknown), (unknown), Kento Imajo, Katsutoshi Sugimoto, (unknown), Hidekatsu Kuroda, Yutaka Yasui, Nobuharu Tamaki, Masayuki Kurosaki, Namiki Izumi, Tomoyuki Akita, Junko Tanaka, Atsushi Nakajima	4
3	Diagnostic performance of shear wave measurement in the detection of hepatic fibrosis: A multicenter prospective study 2024 ·Hepatology Research ·Takashi Kumada, Hidenori Toyoda, Sadanobu Ogawa, (unknown), Yuichi Yoshida, (unknown), Masashi Hirooka, Yohei Koizumi, Yoichi Hiasa, Tsutomu Tamai, Ryoko Kuromatsu, Toshihisa Matsuzaki, (unknown), Yoshihiro Kamada, Yoshio Sumida, Junko Tanaka, Masahito Shimizu	2
4	Association Between Introduction of the 23-valent Pneumococcal Polysaccharide Vaccine (PPSV23) and Pneumonia Incidence and Mortality Among General Older Population in Japan: A Community-based Study 2024 ·Journal of Epidemiology ·Aya Sugiyama, Masaaki Kataoka, (unknown), (unknown), (unknown), (unknown), (unknown), Tomoyuki Akita, Shingo Fukuma, Noboru Hattori, Junko Tanaka	0
5	Comparison Between Attenuation Measurement and the Controlled Attenuation Parameter for the Assessment of Hepatic Steatosis Based on MRI Images 2024 ·Liver International ·(unknown), Takashi Kumada, Sadanobu Ogawa, (unknown), Hidenori Toyoda, Masashi Hirooka, Yohei Koizumi, Yoichi Hiasa, Tomoyuki Akita, Junko Tanaka, Masahito Shimizu	4
6	Relationship between clinical symptom profiles and COVID-19 infection status during Delta-dominant period versus Omicron-dominant period—analysis of real-world data collected in Hiroshima Prefecture, Japan 2023 ·International Journal of Infectious Diseases ·(unknown), Odgerel Chimed‐Ochir, (unknown), Junko Tanaka, Hiroki Ohge, Masao Kuwabara, (unknown), Tatsuhiko Kubo	2
7	Development of Social and Emotional (Non-Cognitive) Skills and Practices of Social and Emotional Learning (SEL): 2023 ·The Annual Report of Educational Psychology in Japan ·(unknown), (unknown), Junko Tanaka, Eriko Harada, (unknown), (unknown), (unknown), (unknown)	1
8	Combined ultrasound and magnetic resonance elastography predict hepatocellular carcinoma after hepatitis C virus eradication 2022 ·Hepatology Research ·Takashi Kumada, Hidenori Toyoda, Satoshi Yasuda, Sadanobu Ogawa, (unknown), Toshifumi Tada, Takanori Ito, Yoshio Sumida, Junko Tanaka	6
9	Intra-individual Comparisons of the Ultrasound-Guided Attenuation Parameter and the Magnetic Resonance Imaging–Based Proton Density Fat Fraction Using Bias and Precision Statistics 2022 ·Ultrasound in Medicine & Biology ·Takashi Kumada, Sadanobu Ogawa, (unknown), Hidenori Toyoda, Satoshi Yasuda, Takanori Ito, Eisuke Yasuda, Tomoyuki Akita, Junko Tanaka	5
10	Factors linked to hepatocellular carcinoma development beyond 10 years after viral eradication in patients with hepatitis C virus 2022 ·Journal of Viral Hepatitis ·Takashi Kumada, Hidenori Toyoda, Satoshi Yasuda, Takanori Ito, Kunihiko Tsuji, Shinichi Fujioka, Atsushi Hiraoka, Kazuya Kariyama, Kazuhiro Nouso, Toru Ishikawa, Tsutomu Tamai, Toshifumi Tada, Junko Tanaka	8
11	Prevalence of fatty liver and advanced fibrosis by ultrasonography and FibroScan in a general population random sample 2022 ·Hepatology Research ·Yuko Nagaoki, Aya Sugiyama, (unknown), (unknown), (unknown), (unknown), Serge Ouoba, (unknown), Ko Ko, Tomoyuki Akita, (unknown), Takashi Kumada, Kazuaki Chayama, Junko Tanaka	7
12	Epidemiological assessment of interventions to eliminate mother‐to‐child transmission of hepatitis B virus in japan 2021 ·Aya Sugiyama, (unknown), Ko Ko, Masayuki Ohisa, Tomoyuki Akita, Takaji Wakita, Junko Tanaka	2
13	Effect of Early Rehabilitation on Gait, Wound and Home Discharge in Lower Extremity Chronic Wound Patients: A Japanese Multicenter Retrospective Study 2021 ·The International Journal of Lower Extremity Wounds ·Noriaki Maeshige, Hisae Hayashi, Hiroto Terashi, Miki Fujii, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Junko Tanaka, Takehiko Ohura, (unknown)	2
14	Pretreatment non‐hypervascular hypointense nodules on Gd‐EOB‐DTPA‐enhanced MRI as a predictor of hepatocellular carcinoma development after sustained virologic response in HCV infection 2021 ·Alimentary Pharmacology & Therapeutics ·Hidenori Toyoda, Satoshi Yasuda, (unknown), Yasuhiro Sone, Atsuyuki Maeda, Yuji Kaneoka, Takashi Kumada, Junko Tanaka	6
15	Lack of hepatitis C virus reinfection in lifetime of Japanese general population with previous hepatitis C virus (HCV) infection successfully treated with anti-HCV therapy 2021 ·Journal of Infection and Chemotherapy ·Hidenori Toyoda, Satoshi Yasuda, (unknown), Takashi Kumada, Junko Tanaka	3
16	Predicting the presence of breast cancer using circulating small RNAs, including those in the extracellular vesicles 2020 ·Cancer Science ·(unknown), Yasuhiro Tsutani, (unknown), (unknown), Yuta Ibuki, Shinsuke Sasada, Tomoyuki Akita, Norio Masumoto, Takayuki Kadoya, Yuki Yamamoto, Ryou‐u Takahashi, Junko Tanaka, Morihito Okada, Hidetoshi Tahara	44
17	Long‐term prognosis with or without nucleot(s)ide analogue therapy in hepatitis B virus–related decompensated cirrhosis 2020 ·Journal of Viral Hepatitis ·Takashi Kumada, Hidenori Toyoda, Satoshi Yasuda, (unknown), Takanori Ito, Junko Tanaka	7
18	Effect of bevacizumab plus XELOX (CapeOX) chemotherapy on liver natural killer cell activity in colorectal cancer with resectable liver metastasis 2018 ·Annals of Gastroenterological Surgery ·(unknown), Kohei Ishiyama, Yuka Tanaka, Tsuyoshi Kobayashi, (unknown), (unknown), (unknown), Kazuhiro Taguchi, Junko Tanaka, Koji Arihiro, Hideki Ohdan	4
19	[Epidemiology of Hepatitis Virus Infection and Its Control from the Epidemiological Point of View.] 2016 ·PubMed ·Junko Tanaka, Aya Sugiyama, Masayuki Ohisa, Tomoyuki Akita	1
20	Quantitative Effect of Natural Killer–Cell Licensing on Hepatocellular Carcinoma Recurrence after Curative Hepatectomy 2014 ·Cancer Immunology Research ·Naoki Tanimine, Yuka Tanaka, Tsuyoshi Kobayashi, Hirotaka Tashiro, Daiki Miki, Michio Imamura, Hiroshi Aikata, Junko Tanaka, Kazuaki Chayama, Hideki Ohdan	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact